Representative Morimoto gives a lecture at the Taiwan Science and Technology Forum
On September 9th, our representative Masahiro MorimotoAssociation of East Asian Relations Science and Technology Exchange CommitteeSponsored by "Taiwan Science and Technology Forum, "On the theme of" AI-based existing drug redevelopment methods and intelligence infrastructure in infectious disease pandemics ".
It was in July that the committee received a request for a lecture at the "Taiwan Science and Technology Forum". After seeing FRONTEO's efforts for COVID-7, we asked Morimoto to give a lecture.
Morimoto took the stage in a session called "New Trends in Smart Medical Solutions."HTC Medical Health Division DeepQ Mr. Edward Y. Chang, the president, served as the moderator.ACT GenomicsMr. Chen, Shu-Jen, Chief Technology Officer / Co-founder of Co., Ltd. and Morimoto gave lectures for 40 minutes each.Mr. Chen gave a lecture on the utilization of complex genomic information and the possibility of personalized medicine in cancer treatment under the theme of "Future development strategy of precision medicine using genome big data". I listened to it with great interest.Morimoto introduced the research on drug reperpassing (diversion of existing drugs) utilizing our technology, using the research on COVID-19 as an example, and explained the effectiveness of the AI approach.In addition, we explain how important the intelligence platform using AI is in an emergency, together with the case of our SNS analysis.
During the question and answer session, questions such as "Why can the accuracy be improved even with a small amount of teacher data?" About "Micro AI" (AI that enables high-precision analysis with a small amount of teacher data), which is a feature of FRONTEO's AI. In addition to the comments received, more technically in-depth opinions were exchanged, such as "How to utilize Concept Encoder for personalized medicine," and it was a very meaningful symposium.
The "Taiwan Science and Technology Forum" gave us an opportunity to hear from Taiwan about the fact that they learned about FRONTEO's technology and that they learned about Taiwan's cutting-edge technology. We would like to express our sincere gratitude to everyone at the secretariat.
Articles in the same category
Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI
Parkinson's disease - Analyzing drug discovery targets using paper search AI
Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th
Searching for new targets for sporadic ALS using AI: Become friends with AI
[Webinar held on 3/25] Risk of important information leakage of Japanese companies due to cross-border application of discovery and its response
[On-site seminar held on 3/19] Latest trends in AI and competition law - from a global perspective <Simultaneous interpretation and reception available>
[Webinar held on 3/5] Are you fully prepared for a series of information leaks?: Recommendation of mock training from a crisis management perspective
[3/13 31st Economic Security Study Session] Strategic importance of “India” towards the post-China era
[Webinar held on 3/12] Learning from court precedents: “Initial response and legal measures in cases of trade secrets taken out by retired employees”